Moderna begins next phase of Omicron-specific booster trial as study finds that antibodies remain durable despite 6-fold drop over 6 months
By Jen Christensen, CNN Moderna announced Wednesday that the first participant has been dosed in the company’s Phase 2 clinical trial of a…
Continue Reading